 double-blinded randomized trial hydrocortisone acute hepatic failure Acute Hepatic Failure Study Group Acute Hepatic Failure Study Group AHFSG double-blinded randomized evaluation hydrocortisone patients acute hepatic failure July August period medical centers United Canada trial total patients eligible study analysis Eighteen patients mg hydrocortisone day patients mg hydrocortisone day therapeutic effect hydrocortisone survival rates placebo versus mg versus mg hydrocortisone day Fulminant hepatitis drug hepatotoxicity non-A non-B hepatitis prognosis fulminant differences significant Serum alpha-fetoprotein modest prognostic value survival AHFSG corticosteroid use acute hepatic failure hepatic encephalopathy